RLAY
Price
$3.92
Change
-$0.17 (-4.16%)
Updated
Feb 21 closing price
Capitalization
656.14M
3 days until earnings call
RZLT
Price
$4.53
Change
-$0.10 (-2.16%)
Updated
Feb 21 closing price
Capitalization
274.23M
86 days until earnings call
Ad is loading...

RLAY vs RZLT

Header iconRLAY vs RZLT Comparison
Open Charts RLAY vs RZLTBanner chart's image
Relay Therapeutics
Price$3.92
Change-$0.17 (-4.16%)
Volume$1.43M
Capitalization656.14M
Rezolute
Price$4.53
Change-$0.10 (-2.16%)
Volume$357.98K
Capitalization274.23M
RLAY vs RZLT Comparison Chart
Loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RLAY vs. RZLT commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAY is a Hold and RZLT is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (RLAY: $3.92 vs. RZLT: $4.53)
Brand notoriety: RLAY and RZLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLAY: 65% vs. RZLT: 75%
Market capitalization -- RLAY: $656.14M vs. RZLT: $274.23M
RLAY [@Biotechnology] is valued at $656.14M. RZLT’s [@Biotechnology] market capitalization is $274.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLAY’s FA Score shows that 1 FA rating(s) are green whileRZLT’s FA Score has 0 green FA rating(s).

  • RLAY’s FA Score: 1 green, 4 red.
  • RZLT’s FA Score: 0 green, 5 red.
According to our system of comparison, RZLT is a better buy in the long-term than RLAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 3 TA indicator(s) are bullish while RZLT’s TA Score has 2 bullish TA indicator(s).

  • RLAY’s TA Score: 3 bullish, 5 bearish.
  • RZLT’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than RZLT.

Price Growth

RLAY (@Biotechnology) experienced а -2.00% price change this week, while RZLT (@Biotechnology) price change was -1.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

RLAY is expected to report earnings on May 01, 2025.

RZLT is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($656M) has a higher market cap than RZLT($274M). RLAY YTD gains are higher at: -4.854 vs. RZLT (-7.551). RZLT has higher annual earnings (EBITDA): -71.42M vs. RLAY (-389.45M). RLAY has more cash in the bank: 840M vs. RZLT (108M). RZLT has less debt than RLAY: RZLT (2.08M) vs RLAY (49.8M). RLAY has higher revenues than RZLT: RLAY (10M) vs RZLT (0).
RLAYRZLTRLAY / RZLT
Capitalization656M274M239%
EBITDA-389.45M-71.42M545%
Gain YTD-4.854-7.55164%
P/E RatioN/AN/A-
Revenue10M0-
Total Cash840M108M778%
Total Debt49.8M2.08M2,391%
FUNDAMENTALS RATINGS
RZLT: Fundamental Ratings
RZLT
OUTLOOK RATING
1..100
92
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RLAYRZLT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 19 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEEDX15.15-0.03
-0.20%
JHancock Infrastructure R6
LSVFX10.55-0.05
-0.47%
LSV Global Managed Volatility Instl
GIDUX7.15-0.05
-0.69%
Goldman Sachs Intl Eq Div & Prem R6
SWANX23.68-0.40
-1.66%
Schwab Core Equity
WSTRX47.12-1.18
-2.44%
Macquarie Science and Technology R

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-4.16%
XNCR - RLAY
48%
Loosely correlated
-0.32%
VCYT - RLAY
44%
Loosely correlated
-4.56%
AXON - RLAY
42%
Loosely correlated
-5.28%
BCYC - RLAY
41%
Loosely correlated
-2.83%
FHTX - RLAY
40%
Loosely correlated
-2.79%
More

RZLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RZLT has been loosely correlated with RLAY. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if RZLT jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RZLT
1D Price
Change %
RZLT100%
-2.16%
RLAY - RZLT
33%
Loosely correlated
-4.16%
ABEO - RZLT
29%
Poorly correlated
-0.69%
EDSA - RZLT
27%
Poorly correlated
-2.80%
URGN - RZLT
27%
Poorly correlated
-5.88%
IMNM - RZLT
27%
Poorly correlated
-5.84%
More